Low-dose aspirin
-
Some interesting info about aspirin.
It’s hard to turn around a medical myth, exemplified by the notion that low-dose aspirin is safe and effective in healthy adults for primary prevention of heart disease, especially in people aged 60 years and older. In 2018, 3 pivotal, very large randomized trials were published, consistently showing the risk of major bleeding exceeded the benefit of CV event reduction. Even though it has now been >7 years since these trials were published, a substantial proportion of people of advanced age are still taking low-dose aspirin for primary prevention, mostly as advised by their physicians! In a survey of 160,000 Americans without heart disease, more than 30% of people age 70+ years were taking low-dose aspirin in 2021.
In this post, I’ll review the relevant data for low-dose aspirin, including some nuances, the guidelines, longer follow-up, and the question of use for cancer prevention.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Register Login